Inventor · disambiguated record
Christoph Lengauer
Also filed as: LENGAUER CHRISTOPH
9 granted patents·5 pending applications·38 citations·filing 1997–2019
86Inventor score
Top patents by PatentIndex Score
14 records- 0183US6511818B2Cancer drug screen based on cell cycle uncouplingUNIV JOHNS HOPKINS·Filed 2001·Granted Jan 28, 2003·7 cites·7 claims
- 0279US10407509B2NTRK2 fusionsBLUEPRINT MEDICINES CORP·Filed 2014·Granted Sep 10, 2019·3 cites·8 claims
- 0367US5882865ACancer drug screen based on cell cycle uncouplingUNIV JOHNS HOPKINS·Filed 1997·Granted Mar 16, 1999·19 cites·12 claims
- 0465US10669590B2PIK3CA fusionsBLUEPRINT MEDICINES CORP·Filed 2019·Granted Jun 2, 2020·0 cites·6 claims
- 0560US2019389969A1Ntrk2 fusionsSTRANSKY NICOLAS·Filed 2019·Application pending·0 cites
- 0657US7354703B2Securin is required for chromosomal stability in human cellsUNIV JOHNS HOPKINS·Filed 2001·Granted Apr 8, 2008·3 cites·10 claims
- 0757US2005202465A1Thymidylate synthase gene and metastasisUNIV JOHNS HOPKINS·Filed 2004·Application pending·0 cites
- 0854US10875930B2PIK3C2G fusionsBLUEPRINT MEDICINES CORP·Filed 2014·Granted Dec 29, 2020·0 cites·5 claims
- 0951US7148009B2Cancer drug screen based on cell cycle uncouplingUNIV JOHNS HOPKINS·Filed 2002·Granted Dec 12, 2006·0 cites·21 claims
- 1047US2017044622A1Pik3ca fusionsBLUEPRINT MEDICINES CORP·Filed 2015·Application pending·0 cites
- 1145US5888735ACancer drug screen based on cell cycle uncouplingUNIV JOHNS HOPKINS·Filed 1997·Granted Mar 30, 1999·4 cites·16 claims
- 1239US5879889ACancer drug screen based on cell cycle upcouplingUNIV JOHNS HOPKINS·Filed 1997·Granted Mar 9, 1999·2 cites·8 claims
- 1336US2019192522A1Inhibitors of the fibroblast growth factor receptor 4 in combination with cyclin-dependent kinase inhibitorsBLUEPRINT MEDICINES CORP·Filed 2017·Application pending·0 cites
- 1434US2017044621A1Met fusionsBLUEPRINT MEDICNES CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christoph Lengauer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →